Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cradle

Request full access

AI-powered protein design and engineering platform.

Amsterdam, NetherlandsFounded 2021Biotech & Life Sciences

About Cradle

Cradle Bio B.V. is a Dutch-Swiss biotechnology company that provides a software platform using generative artificial intelligence for protein engineering. Founded in May 2021, the company has headquarters in Amsterdam and an office in Zurich. The founding team includes CEO Stef van Grieken, a former product manager at Google AI and Google X; Jelle Prins, who was an early employee at Uber; Elise de Reus, previously at Zymergen; Eli Bixby from Google Brain; and Harmen van Rossum, who manages the company's wet lab. Their collective background merges expertise in machine learning, software design, and biology. Cradle's core offering is a web-based platform that enables scientists at pharmaceutical, biotech, and industrial companies to accelerate the research and development of protein-based products. The company operates on a software-as-a-service (SaaS) business model, charging a subscription fee for access to its platform. This model allows clients to retain full ownership of their intellectual property without royalty obligations. The platform is utilized across various sectors, including therapeutics, agriculture, food ingredients, and chemicals. Notable clients include Johnson & Johnson, Novo Nordisk, and eight of the top 25 global biopharma companies. The technology applies large language models to biological data, allowing scientists to upload a protein's amino acid sequence and define objectives such as improved stability or binding affinity. The AI then generates and predicts the performance of numerous protein variants, helping researchers select the most promising candidates for lab testing. This iterative process, which feeds experimental results back into the system to refine subsequent designs, can reportedly speed up R&D timelines by a factor of 2 to 12. Cradle maintains its own wet lab in Amsterdam to continuously test, validate, and improve its AI models with proprietary experimental data. Cradle has secured significant funding to support its growth. After a –5.5 million seed round in November 2022, the company raised a $24 million Series A in November 2023, both led by Index Ventures. This was followed by a $73 million Series B round in 2024, led by IVP, bringing the company's total funding to over $100 million. The capital is being used to expand its team, enhance its lab capabilities, and scale commercial operations globally.

Source: Dealroom company data

At a glance

Status
Operational
Employees
124
Open positions
7
Dealroom signal
92.6/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Molecular Biology, Core AI, Synthetic Biology, Alternative Protein
Technology
Artificial Intelligence, Deep Tech, Machine Learning, Deep Learning
Business model
SaaS
Client focus
B2B

Open roles

4 open roles
RoleTeamLocationPosted
Executive AssistantOperationsOperationsZürich · Remote1mo ago
Scientist, Large LibrariesEngineeringEngineeringAmsterdam2mo ago
Enterprise Account ExecutiveSalesSalesBoston · Remote9mo ago
Scientific Advisor, AntibodiesCustomerCustomerBoston · Remote16mo ago
From the company's careers page. Careers page ↗More startups hiring →

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Nov 2024 $73M $292M Index Ventures · Kindred Capital · IVP ↗
SERIES AOther financing Nov 2023 $24M $96M Index Ventures ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cradle website traffic

Latest recorded traffic for Cradle is 28K monthly website visits, down 3.4% over the last three months. Cradle's team grew 20.4% over the past year.

Latest monthly visits28K 3-month web change-3.4% 1-year team growth+20.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Cradle in the Amsterdam ecosystem

Live from Dealroom

The Cradle office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed9 investors entered at this stage

  • Kindred Capital
  • Index Ventures
  • Adriaan Mol
  • John Zimmer
  • Sylvain Gariel
  • Steve Crossan
  • Patrick Hsu
  • Mehdi Ghissassi
  • Feike Sijbesma

Series A1 investor entered at this stage

Team profiled 16 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Cradle’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.